PIII
The table below shows P3 Health Partners's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $386.39M | $345.25M | $355.79M | $373.23M | $362.12M | $379.16M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
P3 Health Partners reported annual revenue of $1.46B for fiscal year 2025. That is down 2.8% from $1.50B in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $145.48M (FY 2019) to $1.46B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $25.54M |
| $22.14M |
| $23.30M |
| $25.00M |
| $27.22M |
| $26.61M |
| Operating income | $8.24M | -$44.22M | -$34.12M | -$38.09M | -$106.99M | -$31.33M |
| Income tax | -$11.00M | $11.00K | $1.98M | $1.07M | -$3.60M | $968.00K |
| Net income | $1.22M | -$31.59M | -$20.36M | -$20.48M | -$46.51M | -$12.02M |
| EPS (diluted) | $0.32 | -$9.67 | -$6.23 | -$6.28 | -$15.70 | -$7.37 |